Related Experiment Video
Updated: Jul 8, 2026
09:07
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Antihistamine effects on experimental middle ear inflammatory model.
Theognosia S Chimona1, John G Panayiotides, Chariton E Papadakis
1Department of Otolaryngology, University of Crete School of Medicine, Crete, Greece. chimonath@yahoo.gr
Summary
Newer antihistamines like levocetirizine and desloratadine effectively treat allergic otitis media by reducing middle ear inflammation. These agents offer a better alternative to older H1 antagonists, with fewer side effects.
Area of Science:
- Otolaryngology
- Allergy and Immunology
- Pharmacology
Background:
- Allergy is a known factor contributing to otitis media.
- Histamine plays a role in middle ear inflammation.
Purpose of the Study:
- To evaluate the histopathologic effects of H1 histamine receptor antagonists in a rabbit model of histamine-induced middle ear inflammation.
- To compare the efficacy of hydroxyzine hydrochloride, desloratadine, and levocetirizine in mitigating allergic middle ear inflammation.
Main Methods:
- Rabbits were pretreated for 3 days with hydroxyzine, desloratadine, or levocetirizine.
- Middle ear inflammation was induced by transtympanic histamine injection.
- Histopathologic parameters including edema, vascular changes, inflammation, eosinophil presence, and fibrosis were assessed using a semi-quantitative grading system.
Main Results:
- Levocetirizine and desloratadine demonstrated superior efficacy compared to hydroxyzine in reducing inflammation and associated histopathologic changes.
- Levocetirizine showed a statistically significant reduction in all seven tested parameters compared to desloratadine.
- All tested antihistamines reduced inflammation, but newer agents were more effective and potentially safer.
Conclusions:
- Antihistamines are validated for treating allergic otitis media with effusion (OME).
- Newer H1 antagonists, such as levocetirizine and desloratadine, are effective alternatives to older agents.
- These newer antihistamines successfully counteract histamine effects with potentially fewer central nervous system-related adverse effects.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:15Upper Respiratory Drugs: First and Second-Generation Antihistamines
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...